Tianjin Weigao Medical Technology Co., Ltd.

The company is based on mass spectrometry technology and molecular diagnostic technology, and is driven by precision medicine research. It provides leading clinical mass spectrometry and molecular diagnostic products to customers in the medical and health industry.
The company's current main products: its truly localized LC-HTQ2020 and WG-TQ series of triple quadrupole liquid-mass spectrometers with independent intellectual property rights, which can be widely used in clinical testing, biopharmaceuticals, food safety, environmental monitoring, medical research and other fields: molecular diagnostic nucleic acid extraction series, reproductive health series, respiratory tract infection series and gene individualization series of detection reagents.
In May 2022, the company reached a strategic cooperation with Aidimai Medical. The two sides focused on the field of clinical therapeutic drug monitoring TDM. With their respective advantages, they aim to provide fully automated full stack therapeutic drug monitoring solutions for the clinic, so that domestic chromatography and mass spectrometry technology can benefit the public. On February 21, 2023, the Chinese Academy of Sciences Dalian Institute of Chemical Physics - Weigao Holding Co., Ltd. Mass Spectrometry Analysis Joint Laboratory was established, marking the cooperation between Dalian Chemical Institute and Weigao Group has entered a new height.